NCT05594082进行中（未招募）不适用
Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 150
- 试验地点
- 1
- 主要终点
- PFS
研究概览
简要总结
The aim of this trial is to explore the real-world effectiveness and poteintial predictors in Chinese metastatic breast cancer patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Patients aged over 18 years old.
- •Metastatic breast cancer included unresectable locally advanced breast cancer, de novo stage IV breast cancer, and recurrent metastatic breast cancer.
- •Plan to receive or has received Trastuzumab Deruxtecan monotherapy
- •Available medical history.
排除标准
- •Incomplete medical history.
- •Pregnancy or breast-breeding
结局指标
主要结局
PFS
时间窗: 6 weeks
progression-free survival
次要结局
- ORR(6 weeks)
- OS(6 weeks)
- CBR(6 weeks)
- Number of participants with treatment-related adverse events as assessed by CTCAE v4.0(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -Metabolic SyndromeObesityNCT02651454Gachon University Gil Oriental Medical Hospital120
已完成
不适用
Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic SyndromeAcute Kidney InjuryNephropathyNephrotic SyndromeNCT06071533First Affiliated Hospital of Wenzhou Medical University441
Unknown
不适用
Paclitaxel Eluting Balloon Catheter in Coronary De-novo Lesions Treatment in ChinaCoronary DiseaseNCT03466749Xijing Hospital600
已完成
不适用
A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseHand, Foot and Mouth DiseaseNCT01182532The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine3,000
已完成
4 期
A Real-world Study of DEXYCU in the Treatment of Inflammation After Cataract SurgeryInflammationCataractNCT06497699Ocumension Therapeutics (Shanghai) Co., Ltd263